Impact of One-Stop Clinics on Breast Cancer Diagnosis

This whitepaper presents research on the impact of One-Stop Clinics on breast cancer diagnosis and health provider outcomes. It begins by outlining the current challenges faced in the traditional breast cancer diagnostic process, which often leads to significant delays in treatment. The paper details a study conducted by Frost & Sullivan in collaboration with GE HealthCare, involving a survey of healthcare administrators and clinical decision-makers across various U.S. healthcare facilities. The research aims to quantify the time and effort involved in existing workflows and measure the advantages of a One-Stop Clinic model. The findings indicate that the traditional diagnostic journey can take over 33 days, requiring multiple appointments. In contrast, the One-Stop model proposes a streamlined approach that could potentially reduce the time from diagnosis to treatment plan significantly, emphasizing the need for integrated care in breast cancer management. The paper concludes with a discussion on the potential benefits of adopting this model in improving patient outcomes.